1.Chronic myeloid leukaemia presenting as priapism- how should we treat these?
Htun TH ; Dublin N ; Parameswaran M ; Razack AH ; Chua CB
Journal of University of Malaya Medical Centre 2008;11(1):27-29
Priapism is a urological emergency. The treatment for ischaemic priapism is usually
cavernosal aspiration with or without cavernosal irrigation. Some patients may need surgical intervention
-the various shunt procedures. We report a 21-year-old man with priapism secondary to chronic
myeloid leukemia who needed a combined medical and surgical management. He underwent a spongiocavernosal
shunt as well as cytoreductive chemotherapy to achieve complete detumescence. Therefore,
cytoreductive chemotherapy is an adjunct in diffi cult to treat priapism associated with chronic myeloid
leukemia
Leukemia, Myeloid
2.A Case of Myeloid Sarcoma Masquerading as Neuroblastoma
Malaysian Journal of Medicine and Health Sciences 2019;15(2):157-159
Myeloid sarcoma (MS) is an uncommon type of malignancy, and its diagnosis is comparable to acute myeloid leukaemia (AML). In the rare circumstances in which MS does present without AML, it is known as MS de novo. We report a case of a 10-month old child who presented with bilateral proptosis and a pelvic mass due to synchronous primary MS de novo. She was initially misdiagnosed with neuroblastoma, which has this typical presentation. The histopathological result from the biopsy of the orbital mass also showed a small blue round cell tumour (SBRCT) as seen in cases of neuroblastoma. However, the diagnosis of MS was confirmed using immunohistochemistry (IHC) from the orbital biopsy specimen, which usually plays a major role in the diagnosis of orbital tumours and as a prognostic indicator. Our patient remains in clinical remission two years after antileukemic treatment, with no relapse or progression to AML.
Myeloid sarcoma
3.Pseudo-Chediak-Higashi granules in myeloid cells in therapy-related AML with RUNX1-RUNX1T1.
Sung Ran CHO ; Joon Seong PARK
Blood Research 2018;53(3):188-188
No abstract available.
Myeloid Cells*
4.Epidural Granulocytic Sarcoma Causing Cord Compression at Thoracic Region in Acute Myelogenous Leukemia: A Case Report.
Woo Min PARK ; Jee Soo JANG ; Chang Hun RHEE ; Ho Shin GWAK ; Seung Hoon LEE
Journal of Korean Neurosurgical Society 2000;29(11):1533-1537
No abstract available.
Leukemia, Myeloid, Acute*
;
Sarcoma, Myeloid*
5.Sumary of the duration of the phase transfer of chronic myeloid leukemia
Journal of Vietnamese Medicine 2001;257(3):1-4
A restrospective study carried out on 309 patients with chronic myelogenous leukemia treated from 1990 to 10/2000 showed that; -88 cases (28.3%) converted to the blast crisis. - 89.77% of these cases developed acute myeloblastic leukemia (AML) and 9.09% developed ALL.-The percentage of male and female were 55.68% and 44.31% - 45.45% of these converted cases occurred in the age group of 30-50. The youngest age was 10 months and the oldest age was : 72 years old. Mean of duration of the chronic phase was 2.5 years.
Leukemia, Myeloid, Chronic
;
Leukemia, Myeloid, Chronic-Phase
6.A case of weakened group B antigen in a patient with acute myeloblastic leukemia.
Chaeseung LIM ; Yunjeong CHO ; Youngkee KIM
Korean Journal of Blood Transfusion 1991;2(2):211-214
No abstract available.
Humans
;
Leukemia, Myeloid, Acute*
7.Risk-adopted therapy for acute myelogenous leukemia.
Korean Journal of Medicine 2005;69(2):126-134
No abstract available.
Leukemia, Myeloid, Acute*
8.Primary Granulocytic Sarcoma of the Skin without Hematologic Disorders.
Akihiko UCHIYAMA ; Sei ichiro MOTEGI ; Kazuya YAMADA ; Hiroo AMANO ; Osamu ISHIKAWA
Annals of Dermatology 2014;26(5):653-655
No abstract available.
Sarcoma, Myeloid*
;
Skin*
9.Acute Myelogenous Leukemia.
Korean Journal of Pediatrics 2004;47(Suppl 2):S359-S366
No abstract available.
Leukemia, Myeloid, Acute*
10.A case of familial acute myelogenous leukemia.
Hyun Choon SHIN ; Jin Hak LEE ; Hyuk Pyo LEE ; Tae Hyun UM ; Han Ik CHO ; Seon Yang PARK ; Hyo Seop AHN ; Byoung Kook KIM ; Noe Kyoung KIM ; Kyoung Sik OH ; Myoung Soo LYOU
Korean Journal of Medicine 1993;45(3):388-395
No abstract available.
Leukemia, Myeloid, Acute*